BioStem Technologies, Inc. (BSEM)

Market Cap	132.09M
Revenue (ttm)	16.69M
Net Income (ttm)	-6.68M
Shares Out	16.23M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	2.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,022
Open	8.91
Previous Close	9.01
Day's Range	7.65 - 9.20
52-Week Range	1.20 - 15.50
Beta	1.72
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BSEM

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical pr...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: BSEM

Financial Performance

In 2023, BSEM's revenue was $16.69 million, an increase of 142.69% compared to the previous year's $6.88 million. Losses were -$8.48 million, 19.9% more than in 2022.

Financial numbers in USD